HER2-Modulation „beyond“ Trastuzumab | SPECTRUM Onkologie
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - ScienceDirect
Dissecting the biological heterogeneity of HER2-positive breast cancer - ScienceDirect
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text
Figure 1 from STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits | Semantic Scholar
HER2 - Wikipedia
Clinical applications of mouse models for breast cancer engaging HER2/neu
Cancers | Free Full-Text | Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs
Der humane epidermale Wachstumsfaktor-Rezeptor 2 (HER2)
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss | PLOS ONE
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram
HER2-positive breast cancer - The Lancet
Epigenetic downregulation of HER2 during EMT leads to tumor resistance to HER2-targeted therapies in breast cancer | bioRxiv
Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge | Future Oncology
Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... | Download Scientific Diagram
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions | Nature Communications
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR | Oncogene
Real-time detection of cancer marker, HER2, using a... | Download Scientific Diagram
HER2 status in breast Cancer: What does it mean? - Moose and Doc
Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression | PLOS ONE
Breast Cancer Tumor Markers | GeneTex
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology
